此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Telemedicine Enabling Patients in Self-care Behaviors

2021年9月21日 更新者:Kathleen Fasing、University of Michigan
The purpose of the study is to see if monthly telemedicine computer visits (visits using the computer) improve the time it takes to identify and treat an arrhythmia. The second purpose is to see if monthly telemedicine computer visits improves the participant's understanding of the arrhythmia and improves how the participant feels with daily activities.

研究概览

详细说明

Study will utilize the Telemedicine group and the Standard Visit group (30 patients each group) to determine

Endpoints:

  1. Time of recognition, time of diagnosis and time of intervention for arrhythmia. These times will be noted for each patient in each group and look for any difference in these times based upon gaining information from telemedicine visits versus 6 month follow up visit.
  2. Three surveys of patient Self efficacy of medications, activity, and arrhythmia knowledge utilizing three surveys in each group. Surveys will be answered at the start of the study and end of the study by every patient within each group.

Surveys:

MUSE- Medication Understanding and Self Efficacy Tool Shortened FSES- Functioning self efficacy scale ASTA- Arrhythmia specific symptoms and health related quality of life in connection with heart rhythm disturbance

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Michigan
      • Ann Arbor、Michigan、美国、48109
        • University of Michigan

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Read and speak English
  • 18 years of age or older
  • Have a cardiac arrhythmia diagnosis
  • Are willing to participate in the study and answer a pre and post survey.

Exclusion Criteria:

  • Any difficulty in understanding the study
  • Does not have internet or a cell phone data plan
  • Any life threatening arrhythmias
  • Objection to working with nurse practitioners and physician assistants

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
有源比较器:Standard of care group
Discuss new arrhythmias, review symptoms, discuss methods to help symptoms, questions and answers, monitor devices every 3 months
Visits every 6 months is standard of care.
其他名称:
  • 远程医疗
实验性的:Telemedicine group
Discuss new arrhythmias, review symptoms, discuss methods to help symptoms, questions and answers, monitor devices every 3 months
Conduct monthly telemedicine 'skype' visit
Review details of medication indication and use, activity recommendations and changes, and knowledge of arrhythmia changes and activities which are helpful with arrhythmia changes.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Time of recognition of an arrhythmia
大体时间:Up to 6 months
Patient recognition of a probable arrhythmia
Up to 6 months
Time of diagnosis of arrhythmia
大体时间:Up to 6 months
Time of diagnosis of arrhythmia by medical staff- at what point is the diagnosis present.
Up to 6 months
Time to treatment initiation of arrhythmia
大体时间:Up to 6 months
The time- what point in time is the treatment plan innitiated
Up to 6 months

次要结果测量

结果测量
措施说明
大体时间
Change in self efficacy in medication use score as measured by the Medication Self Efficacy Tool (MUSE) survey
大体时间:Baseline, 6 months
MUSE is 7 items which are evaluated to identify if the patient has a good overall understanding and perception of their medicine.
Baseline, 6 months
Change in functioning self efficacy score as measured by the 13 Item Shortened Function Self-efficacy Scale (FSES)
大体时间:Baseline, 6 months
The FSES is 13 questions with responses scored from 1 to 5 with a maximum score of 65. Higher scores indicates higher level of functioning.
Baseline, 6 months
Change in self-efficacy of arrhythmia management score as measured by the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmias (ASTA) survey
大体时间:Baseline, 6 months

The ASTA questionnaire is divided into three separate parts.

  • Part 1 is descriptive data that evaluates the patient's latest episode of arrhythmia and his/her pharmaceutical treatment.
  • Part 2 has 9 items and a four point's response scale with response alternatives from 0 to 3: "No (0), Yes, to a certain extent (1), Yes, quite a lot (2) or Yes, a lot (3) ". A summarized score is calculated for the items, a higher score implies higher symptom burden due to the heart rhythm disturbance. Scoring for the ASTA symptom burden scale ranges from 0 (least burdensome) to highest 27 (most burdensome).
  • Part 3 scale has 13 items and describes the arrhythmia's influence on daily life with a seven items physical subscale (items 1-5, 10 and 12) and a six items mental subscale (items 6-9, 11 and 13). The response alternatives from 0 to 3: "No (0), Yes, to a certain extent (1), Yes, quite a lot (2),
Baseline, 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Kathleen Fasing、University of Michigan
  • 学习椅:Hakan Oral, MD、University of Michigan

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年2月26日

初级完成 (实际的)

2021年8月10日

研究完成 (实际的)

2021年9月20日

研究注册日期

首次提交

2020年2月28日

首先提交符合 QC 标准的

2020年3月3日

首次发布 (实际的)

2020年3月5日

研究记录更新

最后更新发布 (实际的)

2021年9月22日

上次提交的符合 QC 标准的更新

2021年9月21日

最后验证

2021年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • HUM00156966

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Standard of care group的临床试验

3
订阅